anayamalik, Author at European Medical Journal - Page 98 of 120

Canadian Wildfires Increase Lung Risks in Eastern US

The growing health crisis posed by wildfire smoke, even from thousands of miles away, was made clear in a recently published study.

UV Radiation and Merkel Cell Cancer Risk

An epidemiological study has shed light on the primary risk factors driving Merkel cell carcinoma (MCC), a rare but aggressive form of skin cancer.

Exploring Botulinum Toxin for Raynaud’s Treatment

Botulinum toxin (BTX), widely known for its cosmetic and neurological applications, is emerging as a potential treatment for Raynaud’s phenomenon (RP), particularly when secondary to scleroderma.

Spinal Implant Infections: Latest Diagnosis and Treatment Updates

Spinal implant infections (SIIs) are a severe complication of instrumented spinal fusion surgeries, posing significant challenges for both diagnosis and management.

Lung–Kidney Link in Cystic Fibrosis Uncovered

A connection between lung health and kidney function in adults with cystic fibrosis (CF), identifying early urinary markers of kidney injury that correlate with neutrophil activation and reduced lung capacity, has been revealed in a new study.

Optimizing Salvage Therapy for Pediatric Hodgkin Lymphoma

Significant advancements in tailoring salvage therapy for pediatric patients with relapsed or refractory classic Hodgkin lymphoma (cHL) have been revealed in a recent clinical trial.

Rethinking Disability Metrics in MS Trials

CRITICAL questions about the utility of PIRA and RAW as outcome measures in clinical trials for RRMS have been investigated in recently published research.

COVID-19 Linked to Faster Kidney Decline

A recent cohort study highlighted a link between COVID-19 infection and accelerated kidney function decline, surpassing declines observed after other respiratory infections like pneumonia.

Premature Rheumatoid Arthritis Death Surge in Native Americans

Native Americans experience the highest premature mortality rates from rheumatoid arthritis (RA) in the United States, according to a comprehensive study analyzing national data from 1999 to 2020.

Breast Cancer's Bone Marrow Spread Linked to Aggressive Traits

A recent study has unveiled a mechanism by which estrogen receptor-positive (ER+) breast cancer cells become more aggressive after spreading to the bone marrow.